A detailed history of Intrua Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Intrua Financial, LLC holds 12,767 shares of ABBV stock, worth $2.24 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
12,767
Previous 13,490 5.36%
Holding current value
$2.24 Million
Previous $2.18 Million 6.74%
% of portfolio
0.41%
Previous 0.5%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $104,553 - $120,408
-723 Reduced 5.36%
12,767 $2.03 Million
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $14,937 - $17,913
108 Added 0.81%
13,490 $0
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $16,642 - $19,087
124 Added 0.94%
13,382 $1.8 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $35,781 - $45,489
-260 Reduced 1.92%
13,258 $2.03 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $569,757 - $706,908
4,317 Added 46.92%
13,518 $2.19 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $63,276 - $80,062
-589 Reduced 6.02%
9,201 $1.25 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $376,443 - $427,319
3,538 Added 56.59%
9,790 $1.06 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $45,555 - $50,751
-433 Reduced 6.48%
6,252 $711,000
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $260,865 - $287,181
2,550 Added 61.67%
6,685 $745,000
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $482 - $652
6 Added 0.15%
4,135 $443,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $165,119 - $193,795
-1,922 Reduced 31.76%
4,129 $409,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $443,961 - $594,087
6,051 New
6,051 $573,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Intrua Financial, LLC Portfolio

Follow Intrua Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.